Published in J Clin Oncol on February 16, 2010
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. JAMA Oncol (2016) 4.90
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. J Clin Invest (2011) 4.41
Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol (2014) 3.73
The role of aspirin in cancer prevention. Nat Rev Clin Oncol (2012) 2.94
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst (2011) 2.27
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med (2011) 2.12
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85
Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer (2011) 1.76
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat (2010) 1.70
The impact of comorbidity on cancer survival: a review. Clin Epidemiol (2013) 1.68
Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PLoS One (2016) 1.52
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer (2011) 1.48
The role of aspirin in women's health. Int J Womens Health (2011) 1.39
GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Mol Cancer Res (2010) 1.28
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat (2011) 1.22
Prostaglandin E2 EP receptors as therapeutic targets in breast cancer. Cancer Metastasis Rev (2011) 1.21
COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostaglandins Other Lipid Mediat (2011) 1.20
Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res (Phila) (2011) 1.20
Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model. Cancer Prev Res (Phila) (2011) 1.19
Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol (2012) 1.17
Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol (2014) 1.15
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat (2011) 1.15
Molecular targets of aspirin and cancer prevention. Br J Cancer (2014) 1.09
Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PLoS One (2012) 1.06
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. Breast Cancer Res Treat (2011) 1.06
Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Res (2012) 1.04
Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf (2010) 1.04
Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst (2012) 1.02
Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J Natl Cancer Inst (2013) 1.02
Low-dose aspirin use and cancer characteristics: a population-based cohort study. Br J Cancer (2013) 0.99
Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res (2013) 0.98
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies. Mol Cancer Res (2015) 0.97
Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma. PLoS One (2013) 0.97
Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer (2014) 0.97
NSAIDs inhibit tumorigenesis, but how? Clin Cancer Res (2013) 0.96
Breast Cancer Research in the Nurses' Health Studies: Exposures Across the Life Course. Am J Public Health (2016) 0.96
Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev (2011) 0.94
Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study. J Clin Oncol (2013) 0.94
The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway. Oncotarget (2012) 0.94
Current strategies for the prevention of breast cancer. Breast Cancer (Dove Med Press) (2014) 0.93
Integrin α3β1 as a breast cancer target. Expert Opin Ther Targets (2011) 0.93
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer. Breast Cancer Res (2012) 0.92
Analgesic use and the risk of hearing loss in women. Am J Epidemiol (2012) 0.91
Results of observational studies: analysis of findings from the Nurses' Health Study. PLoS One (2014) 0.91
Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use. Breast Cancer Res Treat (2013) 0.91
A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer. Br J Cancer (2011) 0.90
Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions. Clin Colorectal Cancer (2011) 0.90
Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J Clin Oncol (2010) 0.89
Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. Cancer Causes Control (2012) 0.88
Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes. J Cancer (2013) 0.87
A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis. Int J Cancer (2015) 0.87
A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer. Br J Cancer (2013) 0.87
Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancer. PLoS One (2014) 0.86
Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches. Best Pract Res Clin Anaesthesiol (2013) 0.85
Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention. Exp Cell Res (2013) 0.84
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy. PLoS One (2011) 0.84
Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PLoS One (2012) 0.84
Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study. Cancer Res (2014) 0.83
Statin use and breast cancer survival: a nationwide cohort study in Scotland. BMC Cancer (2016) 0.83
Plasma carotenoids and risk of breast cancer over 20 y of follow-up. Am J Clin Nutr (2015) 0.83
Physiological COX-2 expression in breast epithelium associates with COX-2 levels in ductal carcinoma in situ and invasive breast cancer in young women. Am J Pathol (2014) 0.83
Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden. BMC Cancer (2014) 0.82
An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study. Cancer Med (2016) 0.81
Cyclophosphamide and epirubicin-induced diabetes mellitus in breast cancer: A rare occurrence. J Pharmacol Pharmacother (2016) 0.81
Aspirin therapy for cancer: it is never too late. Br J Cancer (2011) 0.81
Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest (2015) 0.81
Clinical evidence for the use of aspirin in the treatment of cancer. Ecancermedicalscience (2013) 0.81
Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition. J Pharmacol Exp Ther (2013) 0.81
Low-dose aspirin and survival from lung cancer: a population-based cohort study. BMC Cancer (2015) 0.81
Ductal carcinoma in situ of the breast: a surgical perspective. Int J Surg Oncol (2012) 0.80
DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: a cross-sectional analysis. BMC Cancer (2012) 0.80
Origin, Methods, and Evolution of the Three Nurses' Health Studies. Am J Public Health (2016) 0.80
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells. Sci Rep (2016) 0.80
Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women. Mayo Clin Proc (2015) 0.79
Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice. BMC Cancer (2014) 0.78
Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint. Clin Epidemiol (2012) 0.78
Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production. PLoS One (2016) 0.78
Fatty acid metabolites in rapidly proliferating breast cancer. PLoS One (2013) 0.78
Preventative therapies for healthy women at high risk of breast cancer. Cancer Manag Res (2014) 0.78
Time scale in follow-up studies: considering disease prognosis. Epidemiology (2013) 0.77
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. Contemp Clin Trials (2016) 0.77
Opioids and breast cancer recurrence: A Danish population-based cohort study. Cancer (2015) 0.77
Combined effects of circulating levels of 25-hydroxyvitamin d and Th1 and th2 cytokines on breast cancer estrogen receptor status. Cancers (Basel) (2014) 0.77
Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink. Breast Cancer Res (2014) 0.77
Aspirin use is associated with decreased risk of breast cancer recurrence and death. J Midwifery Womens Health (2010) 0.77
Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control. Surg Neurol Int (2015) 0.77
Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011. Ecancermedicalscience (2012) 0.77
Do cancer survivors develop healthier lifestyle behaviors than the cancer-free population in the PLCO study? J Cancer Surviv (2016) 0.77
n-3 Polyunsaturated Fatty Acids and their Role in Cancer Chemoprevention. Curr Pharmacol Rep (2015) 0.76
Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin. Br J Pharmacol (2012) 0.76
Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study. Breast Cancer Res Treat (2014) 0.76
Phospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effect. PLoS One (2014) 0.76
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts. Breast Cancer Res (2016) 0.75
The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives. Breast Care (Basel) (2016) 0.75
Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling. Cancer Res (2016) 0.75
Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification. Sci Rep (2016) 0.75
De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancer. Br J Cancer (2016) 0.75
Long-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and Perspectives. Int Anesthesiol Clin (2016) 0.75
Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients. BMC Cancer (2016) 0.75
Marginal structural models and causal inference in epidemiology. Epidemiology (2000) 33.54
A structural approach to selection bias. Epidemiology (2004) 16.44
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology (2000) 15.40
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med (2001) 4.72
Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst (2008) 3.17
Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest (2000) 3.03
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst (2007) 2.95
Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst (1996) 2.58
Prostaglandins and breast cancer. Lancet (1977) 2.54
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst (2008) 2.44
Breast cancer and NSAID use: a meta-analysis. Br J Cancer (2001) 2.21
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. Am J Epidemiol (2002) 2.02
Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev (2008) 1.93
NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control (2007) 1.58
Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control (2006) 1.52
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res (2008) 1.52
NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat (2006) 1.50
Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol (2007) 1.44
Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.30
Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer. Int J Cancer (2001) 1.24
Prostaglandins in breast cancer: relationship to disease stage and hormone status. Br J Cancer (1983) 1.19
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur J Cancer Prev (2008) 1.18
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial. Br J Cancer (2008) 1.14
NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Res Treat (2007) 1.12
Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer. Anticancer Res (2004) 1.05
Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiol Drug Saf (2008) 1.01
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments. Clin Cancer Res (2004) 1.00
The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11. Anticancer Res (2000) 0.97
Current antiplatelet therapies: benefits and limitations. Am Heart J (2008) 0.96
Phospholipid profiles of invasive human breast cancer cells are altered towards a less invasive phospholipid profile by the anti-inflammatory agent indomethacin. Adv Enzyme Regul (2000) 0.94
Use of inhibitors of prostaglandin synthesis in patients with breast cancer. Adv Prostaglandin Thromboxane Res (1980) 0.91
In vitro capacity of various cyclooxygenase inhibitors to revert immune suppression caused by radiation therapy for breast cancer. Radiother Oncol (1990) 0.89
The modulating effects of flurbiprofen on adriamycin plus vincristine or vindesine in the treatment of advanced breast cancer. Cancer Chemother Pharmacol (1985) 0.86
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol (2005) 17.45
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77
Physical activity and survival after breast cancer diagnosis. JAMA (2005) 8.60
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med (2004) 5.68
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68
A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57
Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol (2005) 4.04
High school dietary dairy intake and teenage acne. J Am Acad Dermatol (2005) 4.00
Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med (2007) 3.91
Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology (2003) 3.90
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma. Arch Ophthalmol (2005) 3.75
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ (2013) 3.67
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65
Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ (2008) 3.58
Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Primary prevention of stroke by healthy lifestyle. Circulation (2008) 3.32
Comparison of optic nerve head measurements obtained by optical coherence tomography and confocal scanning laser ophthalmoscopy. Am J Ophthalmol (2003) 3.29
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst (2004) 3.28
Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol (2011) 3.16
Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry (2009) 3.16
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr (2007) 3.14
Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11
Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol (2004) 3.07
Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06
Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol (2008) 3.04
Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis (2006) 3.03
Sexual orientation, health risk factors, and physical functioning in the Nurses' Health Study II. J Womens Health (Larchmt) (2004) 3.01
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med (2010) 2.95
Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92
Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One (2008) 2.92
Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol (2004) 2.90
Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med (2007) 2.90
Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS (2011) 2.85
Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis (2009) 2.84
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80
Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76
Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2004) 2.75
Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol (2004) 2.72
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Mercury and the risk of coronary heart disease in men. N Engl J Med (2002) 2.71
Retracted Multiple sclerosis and Epstein-Barr virus. JAMA (2003) 2.68
Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66
Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum (2004) 2.62
Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60
A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology (2009) 2.56
Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr (2007) 2.56
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54
Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. Am J Epidemiol (2014) 2.53
Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation (2003) 2.52
A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol (2007) 2.50
Physical activity and risk of coronary heart disease in India. Int J Epidemiol (2004) 2.48
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res (2011) 2.40
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37
Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA (2011) 2.34
Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34
Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology (2005) 2.33
Milk consumption and acne in teenaged boys. J Am Acad Dermatol (2008) 2.33
Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med (2007) 2.30
Night work and risk of breast cancer. Epidemiology (2006) 2.30
Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am J Clin Nutr (2003) 2.29
Night shift work and the risk of endometrial cancer. Cancer Res (2007) 2.28
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res (2006) 2.27
Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA (2013) 2.26
A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 2.23
Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA (2005) 2.23
White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch Intern Med (2010) 2.22